Lead Sponsor

Edwards Lifesciences

Age

12 - 18 years

Sex

ALL

Healthy Volunteers

No

•Subjects who are 12 to 18 years of age
•Subjects who have signed the Informed Consent Form
•Subjects who are projected to receive Swan-Ganz catheter as part of procedure/standard of care with intermittent cardiac output measures
•For those Subjects who have had a cardiac transplant,Subjects who are at least 2 weeks post cardiac transplantation
•Subjects with planned pressure monitoring with an arterial line

•Subjects with contraindications for Pulmonary Artery Catheters Placement and monitoring (recurrent sepsis, or with hypercoagulopathy);
•Subjects with contraindications for Arterial Line Placement;
•Subjects with an extreme contraction of the smooth muscle in the arteries and arterioles in the lower arm and hand (i.e., Raynaud's Disease).
•Subjects with a physical site area too limited for proper Sensor placement
•Subjects with finger size less than the smallest finger cuff size
•Documented ≥ moderate pulmonary hypertension (PAPm \> 25mmHg, PVRI \> 3.0 WUxm2)
•Presence of intracardiac shunting (i.e., ASD, VSD)
•Aorto-pulmonary collaterals
•≥ Moderate tricuspid regurgitation, per echocardiogram criteria
•\> Moderate Aortic or pulmonary regurgitation, per echocardiogram criteria
•Persistent cardiac arrythmias during the cardiac catheterization period (\> 3min)
•Vascular abnormalities of the arterial system (i.e., connective tissue disorders, mid-aortic syndrome)

Related studies

NCT06956781 · PTSD, Trauma, and more

NCT06867289 · Procedural Sedation and Analgesia, Pediatric ALL

NCT07257419 · Relapsed Pediatric ALL, Hematopoietic Cell Transplantation, and more

NCT03938987 · Relapsed Non Hodgkin Lymphoma, Relapsed Adult ALL, and more

NCT04575883 · Congenital Heart Disease, Pediatric ALL

Pediatric Cardiac Output Monitoring Observational Study